WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Stock Ownership - Who owns Biocryst Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biocryst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jill C. MilneDirector2026-08-311,288$9.70
$12.49kBuy
Jon P. StonehouseDirector2026-08-31644$9.70
$6.25kBuy
Vincent MilanoDirector2026-08-311,159$9.70
$11.24kBuy
Amy E. McKeeDirector2026-08-31644$9.70
$6.25kBuy
Steven FrankDirector2026-08-311,288$9.70
$12.49kBuy
Vincent MilanoDirector2026-05-291,122$8.91
$10.00kBuy
Steven FrankDirector2026-05-291,262$8.91
$11.24kBuy
Jon P. StonehouseDirector2026-05-29631$8.91
$5.62kBuy
Amy E. McKeeDirector2026-05-29631$8.91
$5.62kBuy
Jill C. MilneDirector2026-05-291,262$8.91
$11.24kBuy

1 of 5

BCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCRX insiders and whales buy or sell their stock.

BCRX Shareholders

What type of owners hold Biocryst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP8.43%21,543,334$182.47MInsider
Baker Brothers Life Sciences Capital GP LLC1.50%3,841,124$32.53MInsider
William W. Featheringill1.16%2,965,110$25.11MInsider
Baker Biotech Capital GP LLC0.60%1,522,015$12.89MInsider
Jon P. Stonehouse0.59%1,500,419$12.71MInsider
Carl L. Gordon0.43%1,100,000$9.32MInsider
Charles K. Gayer0.37%952,583$8.07MInsider
William M. Spencer Iii0.21%543,109$4.60MInsider
Joseph H. Sherrill Jr.0.18%451,900$3.83MInsider
Alane P. Barnes0.16%400,703$3.39MInsider

1 of 3

BCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCRX0.10%15.10%Net SellingNet Buying
PVLA0.10%42.69%Net SellingNet Selling
LKFT0.05%0.00%
VCEL0.11%10.19%Net SellingNet Buying
RXRX0.07%13.66%Net SellingNet Selling
View Top Biotech Stocks

Biocryst Pharmaceuticals Stock Ownership FAQ

Who owns Biocryst Pharmaceuticals?

Biocryst Pharmaceuticals (NASDAQ: BCRX) is owned by 0.10% institutional shareholders, 15.10% Biocryst Pharmaceuticals insiders, and 84.80% retail investors. Baker Bros Advisors LP is the largest individual Biocryst Pharmaceuticals shareholder, owning 21.54M shares representing 8.43% of the company. Baker Bros Advisors LP's Biocryst Pharmaceuticals shares are currently valued at $177.62M.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.